Wolfgang Miesbach on Fernando Corrales-Medina’s Team’s Latest Cross-Sectional Study on Haemophilia
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
”Cardiovascular risk in haemophilia begins very early.
Fernando Corrales-Medina and colleagues have published an important cross-sectional study in Haemophilia evaluating carotid intima–media thickness (cIMT) as a marker of subclinical atherosclerosis in adolescent males with severe haemophilia A or B, all on prophylaxis.
Using bilateral carotid ultrasound, they compared 22 adolescents with severe haemophilia to 16 age‑matched healthy controls:
- Higher cIMT in haemophilia
Right-sided cIMT was significantly increased in adolescents with severe haemophilia compared with controls, despite similar age, BMI, waist circumference, and blood pressure. - Early vascular remodelling
Age- and height-adjusted cIMT percentiles were higher in the haemophilia cohort, suggesting that arterial changes may already begin in adolescence. - Beyond traditional risk factors
HDL cholesterol was lower in the haemophilia group, but cIMT did not correlate with conventional cardiovascular risk factors, highlighting that haemophilia-specific factors and lifelong treatment conditions may also contribute to vascular risk.
For a community that has rightly focused for decades on bleeding outcomes, this work is a strong reminder that comprehensive haemophilia care should systematically integrate cardiovascular risk assessment—starting in paediatric and adolescent age.
Non-invasive tools such as cIMT may become valuable adjuncts to long-term follow-up strategies in this emerging at-risk population.”
Read the full article here.
Article: Carotid Intima-Media Thickness as a Marker of Subclinical Atherosclerosis in Adolescents With Severe Haemophilia
Authors: Alyson Trillo, Juanita Hunter, Audrey Ofir, Jamie Shoag, Joanna A. Davis, Fernando Corrales-Medina
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 12, 2026, 14:27Moustafa Abdou: Paroxysmal Nocturnal Hemoglobinuria From a Rare Disease to a Treatable Condition
-
Apr 12, 2026, 14:18Jean Jacques Kiladjian: Grateful to the MSH for the invitation to ‘Highlights of ASH’ in Asia-Pacific 2026
-
Apr 12, 2026, 14:15Paritosh Garg: A fibrotic marrow is not always PMF
-
Apr 12, 2026, 14:13Scott Woller: ACC/AHA Guidelines and the Role of Pulmonary Embolism Response Teams
-
Apr 12, 2026, 13:55Ifeanyichukwu Ifechidere: When Fibrinogen isn’t Really Fibrinogen
-
Apr 12, 2026, 13:53Alan Nurden: A Contemporary Update on the Pathogenesis of Inherited Platelet Dysfunction
-
Apr 12, 2026, 13:47Kalyan Roy: Visual Inspection of Blood Bags and Blood Products
-
Apr 12, 2026, 13:44Francisco Ujueta: PAD VS CAD – Why Individualized Antithrombotic Strategies Matter
-
Apr 12, 2026, 13:42William Aird: Anemia of Inflammation Not Just a Trade-Off but a Possible Compensation